Sheng Ta (1720) released its financial report, showing that its February 2026 monthly revenue was NT$466 million, a 16.4% decrease compared to the same period last year. As a pharmaceutical company in the biotechnology and healthcare industry, its revenue performance may be affected by drug shipment schedules and market demand.
Company Code: 1720
Company Name: Sheng Ta
Industry: Biotechnology and Healthcare
Data Month/Year: 2026-02
Current Month Revenue: 466,104 thousand NTD (NT$466 million)
Year-over-year Change from Same Month Last Year: -16.4%
FACT BOX
- Source: PR Times
- Category: 其他